When would you offer post-operative concurrent chemoradiation in anaplastic thyroid cancer?

Would you consider it for a patient with good PS but with limited metastatic disease? What dose fractionation would you prefer?

Answer from: Radiation Oncologist at Academic Institution

The management of ATC has evolved considerably over recent years with the most significant being a dichotomy of management based on Braf mutation. We typically offer postoperative XRT, including in patients with either a limited or stable DM disease. However, in a multidisciplinary setting, there s...

Comments

Medical Oncologist at Kaiser Permanente
If you have a patient with R1 resection and stage ...

Radiation Oncologist at Mayo Clinic
R1 is a common surgical outcome in many series. Th...

Please select the option that best describes you:

When would you offer post-operative concurrent chemoradiation in anaplastic thyroid cancer?

Related Questions